Chronic granulomatous disease associated with Duchenne muscular dystrophy caused by Xp21.1 contiguous gene deletion syndrome: Case report and literature review
暂无分享,去创建一个
Lili Wang | R. Teng | Liangliang Jiang | L. Dai | Shaohua Bi | Guanghui Liu | M. Teng
[1] J. L. Shephard,et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). , 2021, Blood cells, molecules & diseases.
[2] J. Veltman,et al. Deleterious variants in X-linked CFAP47 induce asthenoteratozoospermia and primary male infertility. , 2021, American journal of human genetics.
[3] R. Śmigiel,et al. Complex glycerol kinase deficiency – long-term follow-up of two patients , 2021, Pediatric endocrinology, diabetes, and metabolism.
[4] A. Fischer,et al. Chronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case Series , 2020, Journal of Clinical Immunology.
[5] B. Lujan,et al. Retinal gene therapy in X-linked retinitis pigmentosa caused by mutations in RPGR: Results at 6 months in a first in human clinical trial , 2020, Nature Medicine.
[6] Hong-Yan Ji,et al. Serum Biomarkers for Early Diagnosis of Chinese X-CGD Children: Case Reports and a Literature Review , 2019, Current Medical Science.
[7] Hans H. Jung,et al. Molecular Basis and Clinical Overview of McLeod Syndrome Compared With Other Neuroacanthocytosis Syndromes: A Review , 2018, JAMA neurology.
[8] H. Shimada,et al. Cytologic and Ultrastructural Findings of Bronchoalveolar Lavage in Patients With Chronic Granulomatous Disease , 2018, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[9] J. O'Sullivan,et al. Stepwise partitioning of Xp21: a profiling method for XK deletions causative of the McLeod syndrome , 2017, Transfusion.
[10] E. Y. Kim,et al. Correlation of Serum Creatine Kinase Level With Pulmonary Function in Duchenne Muscular Dystrophy , 2017, Annals of rehabilitation medicine.
[11] M. Gonçalves,et al. The emerging role of viral vectors as vehicles for DMD gene editing , 2016, Genome Medicine.
[12] M. Chiriacò,et al. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[13] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[14] A. Pathare,et al. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies , 2015, Clinical genetics.
[15] C. Ki,et al. Identification of a Novel Mutation in the CYBB Gene, p.Asp378Gly, in a Patient With X-linked Chronic Granulomatous Disease , 2014, Allergy, asthma & immunology research.
[16] T. Kizaki,et al. Copy Number Variations Due to Large Genomic Deletion in X-Linked Chronic Granulomatous Disease , 2012, PloS one.
[17] M. Yamada,et al. Determination of the deletion breakpoints in two patients with contiguous gene syndrome encompassing CYBB gene. , 2010, European journal of medical genetics.
[18] J. V. van Krieken,et al. Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous disease. , 2008, Medical mycology.
[19] A. Danek,et al. McLeod syndrome: a neurohaematological disorder , 2007, Vox sanguinis.
[20] C. Westhoff,et al. Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases. , 2007, Gene.
[21] P. Tonin,et al. Complex glycerol kinase deficiency leads to psychomotor and body‐growth failure , 2004, Journal of paediatrics and child health.
[22] Marie Lin,et al. Molecular Basis of the Kell-null Phenotype , 2001, The Journal of Biological Chemistry.
[23] Richard B. Johnston,et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.
[24] S. Holland,et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. , 2000, Medicine.
[25] P. Gane,et al. Analysis of deletions in three McLeod patients: exclusion of the XS locus from the Xp21.1-Xp21.2 region. , 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[26] Duchenne. The Pathology of Paralysis with Muscular Degeneration (Paralysie Myosclérotique) , 1867, British medical journal.